[68Ga]3BP-6121

N/A

Report date: 2025/11/14 09:32:40

NME

Base Information

Drug Name[68Ga]3BP-6121

Drug Alias Name[68Ga]3BP-612168Ga-3BP-6121

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionCadherin 3 modulatorsPositron-emission tomography enhancers

TargetsCadherin 3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A